Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 11.95 M9.71 M11.19 M11.83 M 44.68 M Research & development ———— — Operating income -9.63 M-7.28 M-117 K2.38 M -14.65 M Non-Operating Income, Total 375 K473 K446 K514 K 1.81 M Interest expense, net of interest capitalized 2 M1.8 M1.56 M1.44 M 6.8 M Non-Operating Income, excl. Interest Expenses -1.63 M-1.33 M-1.11 M-927 K -5 M Unusual income/expense ———— — Pretax income -11.16 M-8.75 M-1.47 M1.36 M -20.03 M Equity in earnings 97 K-146 K-240 K23 K -266 K Taxes 196 K952 K836 K2.55 M 4.53 M Non-controlling/minority interest ———— — After tax other income/expense -182 K314 K-330 K226 K 28 K Net income before discontinued operations -11.36 M-9.71 M-2.31 M-1.19 M -24.56 M Discontinued operations ———— — Net income -11.36 M-9.71 M-2.31 M-1.19 M -24.56 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -11.36 M-9.71 M-2.31 M-1.19 M -24.56 M Basic earnings per share (Basic EPS) -0.62-0.53-0.12-0.06 -1.33 Diluted earnings per share (Diluted EPS) -0.62-0.53-0.12-0.06 -1.33 Average basic shares outstanding 18.36 M18.42 M18.58 M18.49 M — Diluted shares outstanding 18.36 M18.42 M18.58 M18.49 M — EBITDA -3.58 M-1.06 M4.4 M6.22 M 5.98 M EBIT -9.56 M-7.01 M-1.78 M271 K -18.07 M Cost of revenue 132.29 M117.76 M120.92 M129.88 M 500.85 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 5.98 M5.95 M6.17 M5.95 M 24.05 M